Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.
In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community ...
Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback